| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/24/2009 | WO2008128627A3 Topically applicable fungicide agents for treating nails |
| 09/24/2009 | WO2008030119A9 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 09/24/2009 | US20090239913 Process for the treatment and prevention of diseases caused by fungi |
| 09/24/2009 | US20090239907 Methods and compositions for treating fish diseases |
| 09/24/2009 | US20090239897 Novel compounds |
| 09/24/2009 | US20090239887 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers |
| 09/24/2009 | US20090239885 Inhibitors of nucleoside phoshorylases and nucleosidases |
| 09/24/2009 | US20090239871 antitumor; breast cancer; 8,9-Dimethoxy-2,3-methylenedioxy-5-[2-(N,N-dimethylamino)ethyl]-5H-dibenzo[c,h]1,6-naphthyridin-6-one |
| 09/24/2009 | US20090239866 Peptide deformylase inhibitors |
| 09/24/2009 | US20090239851 Benzothiazinone Derivatives and their Use as Antibacterial Agents |
| 09/24/2009 | US20090239830 Treatment of viral infections by modulation of host cell metabolic pathways |
| 09/24/2009 | US20090239825 Multi-carotenoids compositions and uses therefor |
| 09/24/2009 | US20090239824 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 09/24/2009 | US20090239817 Organic thiophosphate antiretroviral agents |
| 09/24/2009 | US20090239813 Analogs of Alpha Galactosyceramide and Uses thereof |
| 09/24/2009 | US20090239812 Use of c7 sugars in prevention and treatment of mycoses |
| 09/24/2009 | US20090239802 Hsp70 PEPTIDE STIMULATING NATURAL KILLER (NK) CELL ACTIVITY AND USES THEREOF |
| 09/24/2009 | US20090239792 Short fatty acid tail polymyxin derivatives and uses thereof |
| 09/24/2009 | US20090239265 Virus like particles |
| 09/24/2009 | US20090239261 ASSEMBLY OF WILD-TYPE AND CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES (VLPs) |
| 09/24/2009 | US20090238907 Topical Compositions Containing Bacillus Coagulans Extracellular Products and Uses Thereof |
| 09/24/2009 | US20090238881 Ionophore antibiotic formulations |
| 09/24/2009 | US20090238880 Phospholipid-based pharmaceutical formulations and methods for producing and using same |
| 09/24/2009 | US20090238867 Nanoparticulate Anidulafungin Compositions and Methods for Making the Same |
| 09/24/2009 | US20090238850 Antimicrobial materials |
| 09/24/2009 | US20090238844 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 09/24/2009 | US20090238843 Recombinant mva capable of expressing structural hcv antigens |
| 09/24/2009 | US20090238841 Hiv vaccine formulations |
| 09/24/2009 | US20090238829 Stabilized single domain antibodies |
| 09/24/2009 | US20090238822 Chimeric Hepatitis C Virus Antigens For Eliciting an Immune Response |
| 09/24/2009 | US20090238794 Fluorinated macrocyclic compounds as hepatitis c virus inhibitors |
| 09/24/2009 | US20090238790 Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections |
| 09/24/2009 | CA2756115A1 Antiseptic compositions for the treatment of infections |
| 09/24/2009 | CA2755235A1 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 09/24/2009 | CA2719008A1 Fluorinated macrocyclic compounds as hepatitis c virus inhibitors |
| 09/24/2009 | CA2718950A1 Bridged heterocycles as hiv integrase inhibitors |
| 09/24/2009 | CA2718923A1 Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes |
| 09/24/2009 | CA2718693A1 Substituted pyrazolamides and the use thereof |
| 09/24/2009 | CA2717534A1 Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibiotic-resistant staphylococci |
| 09/24/2009 | CA2717440A1 Antiviral formulation |
| 09/24/2009 | CA2711569A1 Composition and methods used during anti-hiv treatment |
| 09/23/2009 | EP2103623A2 Novel macrocyclic inhibitors of Hepatitis C virus replication |
| 09/23/2009 | EP2103608A1 Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion |
| 09/23/2009 | EP2103607A1 1-phenyl 1-thio-d-glucitol derivative |
| 09/23/2009 | EP2103312A1 Preparation for sterilization or disinfection of tissue |
| 09/23/2009 | EP2103308A1 Method for producing a mixture of bacteriophages and its use in therapy of antibiotic-resistant staphylococci |
| 09/23/2009 | EP2103213A1 Antibacterial agent and bactericidal agent |
| 09/23/2009 | EP2102217A2 4- (2-oxo-oxazolidin-3yl)-phenoxymethyle derivativeas as antibacterials |
| 09/23/2009 | EP2102199A1 Antibacterial polycyclic urea compounds |
| 09/23/2009 | EP2102193A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases |
| 09/23/2009 | EP2102180A1 Substituted aminofuranones and their use |
| 09/23/2009 | EP2102154A1 Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof |
| 09/23/2009 | EP2101811A2 Vaccine for periodontitis and methods of use |
| 09/23/2009 | EP2101792A2 Use of carrageenan for treating rhinovirus infections |
| 09/23/2009 | EP2101787A1 Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin |
| 09/23/2009 | EP2101750A2 Water-soluble phenicol prodrugs in a lipophilic vehicle system |
| 09/23/2009 | EP1667715B1 Antigen delivery system |
| 09/23/2009 | EP1490015B1 Novel 2-amino-9-((2-hydroxymethyl) cyclopropylidenemethyl) purines as antiviral agents |
| 09/23/2009 | EP1467989B1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
| 09/23/2009 | EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/23/2009 | EP1448508B1 Double esters |
| 09/23/2009 | EP1377288B1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and use |
| 09/23/2009 | EP1097213B1 Vaccine against staphylococcus intoxication |
| 09/23/2009 | EP0863981B1 Detection, prevention and treatment of papillomatous digital dermatitis |
| 09/23/2009 | CN101538574A Codon-optimized cholera enterotoxin CTB gene and cholera nucleic acid vaccine thereof |
| 09/23/2009 | CN101538572A Recombinant lactic acid bacteria containing recombinant alpha-2b interferon and application thereof |
| 09/23/2009 | CN101538550A Helicobacter pylori viable bacteria carrier vaccine and special recombination bacteria thereof |
| 09/23/2009 | CN101538328A Humanized neutralizing engineered antibody for targeting avian influenza virus H5N1 |
| 09/23/2009 | CN101538327A Anthropogenic H5N1-resisting hemagglutinin protein broad-spectrum neutralising antibody and application thereof |
| 09/23/2009 | CN101538326A Variable region sequence of hepatitis B virus monoclonal antibody, gene engineering antibody containing variable region and application thereof |
| 09/23/2009 | CN101538319A Polypeptide for detecting polytype human papilloma virus and application thereof |
| 09/23/2009 | CN101538293A Method for preparing secoisolariciresinol diglucoside and ferulic acid glucoside or ferulic acid glucoside ethyl ester |
| 09/23/2009 | CN101538268A Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 09/23/2009 | CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/23/2009 | CN101538244A 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 09/23/2009 | CN101538221A Preparation method of Oseltamivir phosphate |
| 09/23/2009 | CN101537189A Aptamer and new use of derivative thereof |
| 09/23/2009 | CN101537188A Pinocembrin and cyclodextrin or cyclodextrin derivative inclusion compound |
| 09/23/2009 | CN101537186A Vaccine freeze-drying protective agent without gelatin |
| 09/23/2009 | CN101537183A Livestock cefquinome solution containing hexacyclic water |
| 09/23/2009 | CN101537179A Long-acting animal rabies vaccine and preparing method thereof |
| 09/23/2009 | CN101537176A Application of staphylococcus lysozyme compound in preparing medicament improving animal health condition |
| 09/23/2009 | CN101537169A Transfer factor solution for livestock and poultry, and preparation method thereof |
| 09/23/2009 | CN101537154A Manufacturing method of medicament for treating ten kinds of diseases |
| 09/23/2009 | CN101537150A Medicine for treating pulmonary tuberculosis |
| 09/23/2009 | CN101537147A Anaesthetic prescription for treating pulmonary tuberculosis and preparation method thereof |
| 09/23/2009 | CN101537139A Chinese traditional medicine preparation for treating hepatitis and preparation method thereof |
| 09/23/2009 | CN101537138A Traditional Chinese medicine hepatitis B powder for eliminating duplication of hepatitis B virus (HBV) and method for manufacturing same |
| 09/23/2009 | CN101537137A Chinese material medical preparation for treating urinary infection |
| 09/23/2009 | CN101537135A Chinese traditional medicine preparation for curing epidemic encephalitis |
| 09/23/2009 | CN101537123A Pharmaceutical composition for curing skin tinea and preparation method thereof |
| 09/23/2009 | CN101537107A External use liniment capable of treating dermatomycosis and preparation method thereof |
| 09/23/2009 | CN101537106A Pharmaceutical composition for curing tinea manus and pedis and preparation method thereof |
| 09/23/2009 | CN101537100A Novel use l of Chinese herbal medicines like Chinese yam, poria cocos, hypoglauca yam, cistanche deserticola and eucommia ulmoies for treating poliomyelitis sequela |
| 09/23/2009 | CN101537086A Pharmaceutical composition for resisting hepatitis B virus, lowering lipid and alleviating fatty live lesions and preparation method thereof |
| 09/23/2009 | CN101537067A Picrorhiza total glucoside phospholipid composition and preparation method thereof |
| 09/23/2009 | CN101537065A Drug composition having functions of cleaning and bacteriostasis |
| 09/23/2009 | CN101537064A Formulation method for treating chicken colibacillosis and pullorosis |
| 09/23/2009 | CN101537063A Formulation method for treating chicken dysentery and toxic heat |
| 09/23/2009 | CN101537060A Medicine for treating AIDS |